代谢综合征相关性眼病的研究进展

Research of metabolic syndrome-associated ophthalmopathy

代谢综合征（MS）是一组复杂的代谢紊乱症候群，包括中心性肥胖、高血糖、高血压、血脂异常等。以往认为代谢综合征使糖尿病、冠心病及其他心血管疾病的危险明显增加。但越来越多的研究显示，MS也是眼部病变的重要致病因素之一。MS及其各组分可能通过多种机制参与眼部疾病的发生、发展，常见的有视网膜病变、青光眼、白内障等。而MS相关性眼病的治疗，除了传统的眼科治疗之外，对MS及其各组分的控制更为重要。

Metabolic syndrome（MS） is a group of complex metabolic disorder,which include central obesity,hyperglycemia, hypertension, dyslipidemia, etc. As is known to all, the risk of developing diabetes mellitus,coronary artery disease and other cardiovascular diseases in patients with MS are increased significantly. But more and more studies have shown that MS is a major factor for ophthalmopathy. Through a variety of mechanisms,MS and its various components lead to the pathogenesis and development of ophthalmopathy such as retinopathy, glaucoma, cataract, and so on. About the treatment of MS-associated ophthalmopathy, in addition to the traditional treatment of ophthalmology,the control of MS and it components appears to be particularly important.